Life Sciences Review

About Us

Conference

Partner With Us

Cell and Gene Therapy Companies

Factors to Consider for Successful Outsourcing in the Cell and Gene Therapy Space

Jay Newman

Executive Director, Global Head

Research and Development Quality

Targeted Gene Therapy Medicines

Advancing RNA Therapies through Smarter Biological Engineering

Elita Montanari

Co-Founder and CTO

EVis Bioscience

Featured Issue

Featured Categories

Targeted Gene Therapy Medicines

The Tipping Point for Scalable Manufacturing Processes to Pivot Gene Therapies

Dr Linda Randall, AVP Biologics Development, Manufacturing & Control Pharmaron

Early Phase Biologics Characterization; a Key Factor for Risks Mitigation in Biologics Product Developments

Rafael Sande, Head Operations Characterization Large Molecule / Cell- and Gene Therapy Services Solvias AG

Pushing the Boundaries of Biopharmaceutical Breakthroughs

Andrea Gough, Director, Solentim Portfolio and Science Applications ; Germar Wittke, Biopharma Sales Director, EMEA

iWisdom: Growth Partnership with Greffex

Simon Ogden Commercialization Partner and Uwe D. Staerz M.D., Ph.D. Co-Chairman & Chief Scientific Officer

Advancing Cell and Gene Therapies with Purpose and Precision

Tine Vander Sype, Senior Manager of Cell, Gene & Advanced Therapies, EMEA

Thermo Fisher Scientific

IWisdom Talks with a Biotech Entrepreneur

Emma Sutton, Managing Director

Greffex

Quest for Musculoskeletal Wellness

Dr. Fahad Attar, Consultant Orthopaedic Surgeon and CEO

Specials

Cell and Gene Therapy Companies

Factors to Consider for Successful Outsourcing in the Cell and Gene Therapy Space

Advancing RNA Therapies through Smarter Biological Engineering

Featured Issue

Featured Categories

Targeted Gene Therapy Medicines

The Tipping Point for Scalable Manufacturing Processes to Pivot Gene Therapies

Early Phase Biologics Characterization; a Key Factor for Risks Mitigation in Biologics Product Developments

Pushing the Boundaries of Biopharmaceutical Breakthroughs

iWisdom: Growth Partnership with Greffex

Advancing Cell and Gene Therapies with Purpose and Precision

IWisdom Talks with a Biotech Entrepreneur

Quest for Musculoskeletal Wellness

News

Evidence before Expansion in Stem Cell Therapy

Molecular Pathology Built Around Clinical Context

Stem Cell Therapy Treatments: Advancing Regenerative Medicine through Cellular Innovation

CMMS and EAM Software: Strengthening Asset Performance across Life Sciences

Upscaling Cell Cultivation Process with Automated Solution

Welcome to Regenesiss: Leading the Charge in Regenerative Medicine

Europe’s Leading Stem Cell Bank

Translating Complex Cell and Gene Therapies into the Clinic